http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0807974-B8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ce92a4d2fdab0cc5440f710c3787f38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c82f1477b71e93f1ff6e9b27d67ec77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
filingDate 2008-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0b2bee96da2a78d3e70e4a1ec5f6aa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eecd217478061ccf2bf1cd0c614ff65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7cc227a68404a54a65458db1fd17516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_488dda72422e0b29e0f9c747b180306e
publicationDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0807974-B8
titleOfInvention crystalline salt form, pharmaceutical composition, process for the preparation of a crystalline salt, adduct and use of the crystalline salt form
abstract crystalline forms of an 8-azabicyclo[3.2.1]octane compound. the invention provides a crystalline salt of 3-endo-(8-{2-[cyclohexylmethyl-((s)-2,3-dihydroxy-propionyl)amino]ethyl}-8-aza-bicyclo[3.2.1] sulfate oct-3-yl) benzamide or a solvate thereof. the invention also provides pharmaceutical compositions comprising these crystalline salt forms, methods of using these crystalline salt forms for the treatment of diseases associated with mu opioid receptor activity, and processes useful for preparing these crystalline salt forms.
priorityDate 2007-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 27.